GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2359.85 and 2462.15
| Intraday Target 1 | 2338.37 |
| Intraday Target 2 | 2381.33 |
| Intraday Target 3 | 2440.6666666667 |
| Intraday Target 4 | 2483.63 |
| Intraday Target 5 | 2542.97 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 13 March 2026 | 2424.30 (-3.2%) | 2500.00 | 2397.70 - 2500.00 | 0.9699 times | Thu 12 March 2026 | 2504.40 (0.74%) | 2486.00 | 2436.80 - 2519.40 | 0.8866 times | Wed 11 March 2026 | 2486.00 (-0.04%) | 2489.50 | 2471.00 - 2541.00 | 0.8043 times | Tue 10 March 2026 | 2487.00 (-1.28%) | 2527.00 | 2473.00 - 2554.00 | 1.1342 times | Mon 09 March 2026 | 2519.20 (0.08%) | 2500.00 | 2450.80 - 2529.90 | 0.8431 times | Fri 06 March 2026 | 2517.30 (1.53%) | 2478.00 | 2470.50 - 2528.90 | 0.621 times | Thu 05 March 2026 | 2479.30 (-0.27%) | 2487.00 | 2450.10 - 2525.00 | 0.8699 times | Wed 04 March 2026 | 2485.90 (-1.84%) | 2501.00 | 2480.00 - 2512.10 | 0.9866 times | Mon 02 March 2026 | 2532.60 (-1.52%) | 2520.00 | 2511.70 - 2581.60 | 2.007 times | Fri 27 February 2026 | 2571.60 (-2.07%) | 2632.10 | 2566.00 - 2633.10 | 0.8774 times | Thu 26 February 2026 | 2626.00 (-1%) | 2650.00 | 2610.00 - 2650.00 | 0.652 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2332.85 and 2489.15
| Weekly Target 1 | 2302.37 |
| Weekly Target 2 | 2363.33 |
| Weekly Target 3 | 2458.6666666667 |
| Weekly Target 4 | 2519.63 |
| Weekly Target 5 | 2614.97 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.7429 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.7183 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.7171 times | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 0.7934 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 2.0567 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 1.0517 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 0.9325 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.2069 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.6601 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 1.1204 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 2.2685 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2319.05 and 2502.95
| Monthly Target 1 | 2283.97 |
| Monthly Target 2 | 2354.13 |
| Monthly Target 3 | 2467.8666666667 |
| Monthly Target 4 | 2538.03 |
| Monthly Target 5 | 2651.77 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 13 March 2026 | 2424.30 (-5.73%) | 2520.00 | 2397.70 - 2581.60 | 0.2664 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.8422 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.7523 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.2295 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.0255 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.6659 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.0607 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.468 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.8963 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.7933 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 3.2202 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2072.55 and 2572.05
| Yearly Target 1 | 1955.3 |
| Yearly Target 2 | 2189.8 |
| Yearly Target 3 | 2454.8 |
| Yearly Target 4 | 2689.3 |
| Yearly Target 5 | 2954.3 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 13 March 2026 | 2424.30 (-1.99%) | 2476.00 | 2220.30 - 2719.80 | 0.1905 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6616 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2629 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2579 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7306 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9746 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0876 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4652 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2366 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1323 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1326 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
But this trend seems to be weakening.Price is below an important level of 2509.43 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears strongly Bearish. This stock started falling as soon as it opened and never recovered during the session. Generally this happens when there is a negative sentiment following the stock, making it unattractive. There's a good chance that this downfall will continue tomorrow as well. However, if it manages to close higher than where it opened today, then there might be a chance of reversal.
Munafa value: 20 as on Fri 13 March 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2555 and price is deviating by 63 points
Upper Bollinger band is at 2680 and lower is at 2431, while middle bands are at 2493 and 2618
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2502.77 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2484.18 |
| 12 day DMA | 2523.84 |
| 20 day DMA | 2554.84 |
| 35 day DMA | 2515.63 |
| 50 day DMA | 2478.48 |
| 100 day DMA | 2519.05 |
| 150 day DMA | 2597.16 |
| 200 day DMA | 2757.78 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2476.75 | 2502.97 | 2502.26 |
| 12 day EMA | 2509.43 | 2524.9 | 2528.63 |
| 20 day EMA | 2520.31 | 2530.41 | 2533.15 |
| 35 day EMA | 2504.2 | 2508.9 | 2509.17 |
| 50 day EMA | 2477.06 | 2479.21 | 2478.18 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2484.18 | 2502.78 | 2497.76 |
| 12 day SMA | 2523.84 | 2540 | 2551.18 |
| 20 day SMA | 2554.84 | 2567.05 | 2576.8 |
| 35 day SMA | 2515.63 | 2514.37 | 2507.91 |
| 50 day SMA | 2478.48 | 2479.47 | 2477.06 |
| 100 day SMA | 2519.05 | 2522.23 | 2524.43 |
| 150 day SMA | 2597.16 | 2599.86 | 2602.29 |
| 200 day SMA | 2757.78 | 2761.25 | 2763.53 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 42.99
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 43.22
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


